Modeling Glioma Intratumoral Heterogeneity with Primary Human Neural Stem and Progenitor Cells

Area of Science:

• Neuro-oncology
• Cancer Biology
• Developmental Neuroscience

Background:

• Glioblastoma multiforme (GBM) exhibits significant intratumoral heterogeneity, contributing to therapy resistance.
• GBM shares similarities with normal brain development's neural stem cell hierarchy.
• The precise role of cell-of-origin in shaping GBM heterogeneity remains unclear.

Purpose of the Study:

• To investigate how the cell-of-origin influences intratumoral heterogeneity in glioblastoma.
• To develop a novel model system for studying glioma initiation and development.
• To systematically analyze the impact of different neural progenitor cell types on tumor landscapes.

Main Methods:

• Isolation and culture of human fetal neural stem cells (NSCs), glial progenitor cells (GPCs), and oligodendrocyte precursor cells (OPCs).
• Genetic modification of these cells with dominant-negative TP53^R175H and NF1 knockdown.
• Transplantation of modified cells into immunodeficient mouse brains and subsequent tumor formation.
• Single-cell RNA sequencing (scRNA-seq) of re-extracted engrafted cells to analyze tumor heterogeneity.

Main Results:

• Reprogrammed neural progenitor cells robustly engrafted and expanded in mouse brains.
• Single-cell RNA sequencing revealed a strong influence of the cell-of-origin on the resulting glioma's cellular subtypes and heterogeneity.
• The study established a versatile platform for dissecting cell-of-origin effects in glioma.

Conclusions:

• The cell-of-origin is a critical determinant of glioblastoma heterogeneity.
• This research provides a powerful experimental system for future studies on glioma development and therapeutic resistance.
• Understanding cell-of-origin effects can inform targeted therapeutic strategies for GBM.